Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 41

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02677519Phase 4Unknown
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
Attention Deficit Disorder With Hyperactivity
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Psychiatry & Behavioral Sciences, Duke University, Durham, NC

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Patrick J. McGrath, PhD.

IWK Health Centre

Moderately Similar
6 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score30%

Daniel S Pine, M.D.

National Institute of Mental Health (NIMH)

Moderately Similar
10 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score30%

Ru-Lan Hsieh, MD

Shin Kong Wu Ho-Su Memorial Hospital

Moderately Similar
13 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score30%

Renana Eitan, MD

Hadassah Medical Organization

Moderately Similar
5 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score30%

Sabine Wilhelm, PhD

Massachusetts General Hospital

Moderately Similar
9 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score30%

Theresa Winhusen, Ph.D.

University of Cincinnati

Moderately Similar
6 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score30%

Karen Sepucha, PhD

Massachusetts General Hospital

Moderately Similar
10 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score30%

Roger deBeus, PhD

Skyland Behavioral Health Associates

Moderately Similar
2 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score30%

Nobuhito Sanada

Otsuka Pharmaceutical Co., Ltd.

Moderately Similar
11 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score30%

Susan Shur-Fen Gau, MD, PhD

Dept of Psychiatry, National Taiwan University Hospital

Moderately Similar
6 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02677519Phase 4PrincipalInvestigator

A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD

Attention Deficit Disorder With Hyperactivity
Unknown

All 1 trials loaded